E for L Aim Public Company Limited - Asset Resilience Ratio
E for L Aim Public Company Limited (EFORL) has an Asset Resilience Ratio of 0.00% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of E for L Aim Public Company Limited for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2021)
This chart shows how E for L Aim Public Company Limited's Asset Resilience Ratio has changed over time. See net assets of E for L Aim Public Company Limited for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down E for L Aim Public Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EFORL market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 0% |
| Short-term Investments | ฿0.00 | 0% |
| Total Liquid Assets | ฿0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: E for L Aim Public Company Limited maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
E for L Aim Public Company Limited Industry Peers by Asset Resilience Ratio
Compare E for L Aim Public Company Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.44% |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332 |
Medical Distribution | 5.56% |
Annual Asset Resilience Ratio for E for L Aim Public Company Limited (2009–2021)
The table below shows the annual Asset Resilience Ratio data for E for L Aim Public Company Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.00% | ฿0.00 ≈ $0.00 |
฿1.68 Billion ≈ $52.28 Million |
-- |
| 2020-12-31 | 0.01% | ฿148.00K ≈ $4.61K |
฿1.56 Billion ≈ $48.52 Million |
+0.00pp |
| 2019-12-31 | 0.01% | ฿148.00K ≈ $4.61K |
฿2.44 Billion ≈ $76.17 Million |
+0.00pp |
| 2018-12-31 | 0.00% | ฿146.00K ≈ $4.55K |
฿3.22 Billion ≈ $100.28 Million |
+0.00pp |
| 2017-12-31 | 0.00% | ฿144.00K ≈ $4.49K |
฿3.89 Billion ≈ $121.11 Million |
+0.00pp |
| 2016-12-31 | 0.00% | ฿142.00K ≈ $4.43K |
฿6.75 Billion ≈ $210.33 Million |
-0.28pp |
| 2015-12-31 | 0.28% | ฿20.73 Million ≈ $646.14K |
฿7.31 Billion ≈ $227.71 Million |
-1.63pp |
| 2014-12-31 | 1.91% | ฿140.78 Million ≈ $4.39 Million |
฿7.37 Billion ≈ $229.60 Million |
+1.31pp |
| 2013-12-31 | 0.61% | ฿5.10 Million ≈ $158.87K |
฿840.99 Million ≈ $26.21 Million |
+0.57pp |
| 2012-12-31 | 0.03% | ฿19.00K ≈ $592.21 |
฿60.86 Million ≈ $1.90 Million |
+0.02pp |
| 2011-12-31 | 0.01% | ฿19.00K ≈ $592.21 |
฿160.42 Million ≈ $5.00 Million |
+0.00pp |
| 2010-12-31 | 0.01% | ฿18.00K ≈ $561.04 |
฿191.26 Million ≈ $5.96 Million |
-0.16pp |
| 2009-12-31 | 0.17% | ฿537.46K ≈ $16.75K |
฿313.14 Million ≈ $9.76 Million |
-- |
About E for L Aim Public Company Limited
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand. The company offers clinical hematology, microscopy, chemistry, immunology, and microbiology related products. It also provides various equipment for medical devices. In addition, the company offers educational, clinical and laboratory microscopes, and scien… Read more